Plant-based diets (“PBD”) decrease the serum levels of inflammation by reducing levels of ROS (https://ibn.fm/tA2MU). Also, chronic neuropathic pain is a common debilitating problem and its treatment presents a major challenge to health care. Studies indicate that plants and some constituents of herbal medicine have the potential to cure neuropathic pain (https://ibn.fm/YjtYW).
Healthy Extracts (OTCQB: HYEX) is a leading researcher and manufacturer of plant-based formulations offering healthy supplements that are beneficial for heart and nerve health. The company continues to strengthen its stronghold in the health and lifestyle industry through its unique assets and operations of subsidiaries BergaMet North America and Ultimate Brain Nutrients (“UBN”).
BergaMet NA operations are centered around the sale and distribution of a full line of proprietary product formulations derived from the rare Citrus Bergamot SuperFruit™ called “bergamot.” Bergamot is uniquely loaded with various antioxidant polyphenols. This Mediterranean fruit supports heart health, reduces stress, anxiety, and improves metabolic health with no known side effects.
The only Citrus Bergamot SuperFruit(TM) heart health supplement backed by 17 clinical studies (https://ibn.fm/Tcmyr), the BergaMet brand supplement is enriched with the world’s best quality polyphenols and flavonoids, benefiting the lives of thousands of people who suffer from heart ailments. It is also the only Bergamot supplement approved by the prestigious Accademia del Bergamotto of Italy.
Healthy Extracts acquired BergaMet NA in 2019, the only company authorized to manufacture, distribute, and sell these products in the United States, Canada, and Mexico. This acquisition move further strengthened Healthy Extracts’ foothold in the broader health industry.
Healthy Extracts Inc. recently announced positive results of clinical studies for two leading products: BergaMet North America’s HERHEART(TM) and Ultimate Brain Nutrients’ Fuel4Thought(TM) Brain Booster. Duke Pitts, CEO of BergaMet North America, stated that HER HEART(TM) is a natural supplement that is scientifically formulated specifically for women to support cardiovascular health, including perimenopausal symptoms (https://ibn.fm/oqbRG).
Cardiovascular disease is the number one cause of death for women in the U.S. The company expects HERHEAT(TM) to become one of its top-selling products, under the leadership of the internationally renowned health expert Dr. Nesochi Okeke-Igbokwe MD., M.S, who recently joined the company’s Medical Advisory Board.
The company’s UBN subsidiary released its study of Fuel4Thought(TM) Brain Booster, showing impressive results in brain activation, sports vision, hand to eye coordination, and auditory reaction time (https://ibn.fm/lgMuj).
For more information, visit the company’s website at www.HealthyExtractsInc.com.
NOTE TO INVESTORS: The latest news and updates relating to HYEX are available in the company’s newsroom at https://ibn.fm/HYEX
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
For cardiovascular conditions, annual health care costs are forecasted to increase from $393 billion in…
About 90% of men that undergo prostate cancer treatment, and almost 50% of men treated…
BioMedWire Editorial Coverage: Cancer research is entering one of its most dynamic periods in decades.…
BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) robs people of control over their own bodies —…
The seriousness of coronary artery disease continues to intensify as populations age and cardiovascular risk…
Aggressive repurchase of its own stock by Earth Science Tech, a growing holding company focused…